167
Participants
Start Date
May 5, 2021
Primary Completion Date
October 31, 2024
Study Completion Date
October 31, 2024
Biomarker Testing (L)
Patients who have received biomarker testing that could affect prognosis or treatment decisions. This generally excludes testing done to assist in the diagnosis of disease or histology where there is no treatment implication from this testing.
Systemic Treatment (T)
Patients who have received any treatment as part of their care. This refers to systemic treatment, but also allows other non-drug related interventions such as surgery or radiotherapy as part of the longitudinal care of the patient.
Patient Reported Outcomes (P)
Patients who have provided information about their disease, treatment course, or experience directly to the study using a patient facing tool or device.
Oncology and Hematology of South Texas, Laredo
Teton Cancer Institute, Idaho Falls
Taproot Health
INDUSTRY